Measuring Gait Variability in Multiple Sclerosis (MS): exploring new markers for clinical monitoring

• Conditions: Multiple Sclerosis; G35; Multiple sclerosis

• Registration Number: DRKS00016156
• Lead Sponsor: Klinikum Bayreuth GmbH, Klinik für Neurologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-15
• Study Completion: 2022-02-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 133

Inclusion Criteria

MS diagnoses based on McDonald criteria; ability to walk for at least six minutes without a walking aid; age range 18-65 years

Exclusion Criteria

Able to walk only with walking aid

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determine sensitivity of inertial sensors to anomalies in gait variability (e.g. MTC-variability) across MS patients with a varying level of disability (EDSS: 0-6).<br>The primary outcome is reached after the gait variability of all MS patients and healthy controls has been analyzed at one time (July 2020).

Secondary Outcome Measures

Name	Time	Method
Determine sufficiency of test-retest reliability of gait variability parameters derived with inertial sensors across a period of 4-6 months.